Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Balabandian

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Experimental Gerontology|July 17, 2022
Metformin use and brain atrophy in nondemented elderly individuals with diabetesFardin Nabizadeh, Samuel Berchi Kankam, Mohammad Balabandian, et al.
Current Journal of Neurology|November 27, 2023
Association of cognitive impairment and quality of life in patients with multiple sclerosis: A cross-sectional studyFardin Nabizadeh, Mohammad Balabandian, Mohammad Reza Rostami, et al.
Pharmacology Research & Perspectives|February 25, 2025
Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine PathwaysMohammad Balabandian, Mohammad Amin Manavi, Ali Lesani, et al.
BMC Cardiovascular Disorders|February 16, 2024
Frailty efficacy as a predictor of clinical and cognitive complications in patients undergoing coronary artery bypass grafting: a prospective cohort studyMehrnoosh Bakhtiari, Farhad Shaker, Fatemeh Ojaghi Shirmard, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Experimental Gerontology|July 17, 2022
Metformin use and brain atrophy in nondemented elderly individuals with diabetesFardin Nabizadeh, Samuel Berchi Kankam, Mohammad Balabandian, et al.
Current Journal of Neurology|November 27, 2023
Association of cognitive impairment and quality of life in patients with multiple sclerosis: A cross-sectional studyFardin Nabizadeh, Mohammad Balabandian, Mohammad Reza Rostami, et al.
Pharmacology Research & Perspectives|February 25, 2025
Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine PathwaysMohammad Balabandian, Mohammad Amin Manavi, Ali Lesani, et al.
BMC Cardiovascular Disorders|February 16, 2024
Frailty efficacy as a predictor of clinical and cognitive complications in patients undergoing coronary artery bypass grafting: a prospective cohort studyMehrnoosh Bakhtiari, Farhad Shaker, Fatemeh Ojaghi Shirmard, et al.
Pageof 2